Barratt, J. Et Al. 2024. WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL. KIDNEY INTERNATIONAL REPORTS , vol.9, no.4 , 174.

Barratt, J., Kristensen, J., Stone, A., Floege, J., Tesař, V., Trimarchi, H., ... Zhang, H.(2024). WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL. KIDNEY INTERNATIONAL REPORTS , vol.9, no.4, 174.

Barratt, Jonathan Et Al. "WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL," KIDNEY INTERNATIONAL REPORTS , vol.9, no.4, 174, 2024

Barratt, Jonathan Et Al. "WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL." KIDNEY INTERNATIONAL REPORTS , vol.9, no.4, pp.174, 2024

Barratt, J. Et Al. (2024) . "WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL." KIDNEY INTERNATIONAL REPORTS , vol.9, no.4, p.174.

@article{article, author={Jonathan Barratt Et Al. }, title={WCN24-1776 NEFECON EFFECT ON QUALITY OF LIFE IN PATIENTS WITH IgAN: SF-36 RESULTS FROM THE PHASE 3 NeFIgArd TRIAL}, journal={KIDNEY INTERNATIONAL REPORTS}, year=2024, pages={174} }